EXACT Sciences Corp (NASDAQ:EXAS)

CAPS Rating: 2 out of 5

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.

EXAS News and Commentary

Caps

How do you think EXAS will perform against the market?

Add Stock to CAPS Watchlist

All Players

245 Outperform
38 Underperform
 

All-Star Players

50 Outperform
16 Underperform
 

Wall Street

13 Outperform
1 Underperform
 

Top EXAS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

ELPastor (< 20)
Submitted October 27, 2014

Most people, it is safe to say, do not enjoy getting a colonoscopy. Therefore, any company that offers a non-invasive colorectal cancer screening test has a good chance of squeezing out a nice, large profit.

zzlangerhans (99.53)
Submitted June 26, 2016

Exact stock does well when something happens to fuel speculation about the long-term profitability of Cologuard, and badly when actual quarterly revenues and losses are released. That reminds me of another stock that has a large cult following and… More

EXAS VS S&P 500 (SPY)

Fools bullish on EXAS are also bullish on:

Fools bearish on EXAS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EXAS.

Recs

0
Member Avatar TMFTypeoh (94.27) Submitted: 4/5/2018 7:25:21 AM : Outperform Start Price: $41.09 EXAS Score: +52.68

Man on man is this company expensive, but its got a huge opportunity ahead.

Recs

0
Member Avatar brandstudere (94.32) Submitted: 3/7/2018 6:25:35 AM : Outperform Start Price: $38.49 EXAS Score: +55.09

Unmet needs in CRC screening; helping to close the gap in screening rates.
Pipeline can provide significant tailwinds for years to come.

Recs

0
Member Avatar 407rotorhead (49.38) Submitted: 10/20/2017 3:41:12 PM : Outperform Start Price: $48.94 EXAS Score: +23.94

Age increasing in population requiring colon screenings. This is an easy way to complete these screenings. Medicare approved.

Leaderboard

Find the members with the highest scoring picks in EXAS.

Score Leader

proisback

proisback (57.31) Score: +1,988.76

The Score Leader is the player with the highest score across all their picks in EXAS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
proisback 57.31 9/24/2009 Outperform 3M $2.88 +2,150.00% +162.46% +1,987.54 1 Comment
theonlypro4U < 20 9/23/2009 Outperform 3M $2.89 +2,142.21% +159.61% +1,982.61 1 Comment
chas1232123 < 20 9/23/2009 Outperform 3Y $2.91 +2,126.88% +160.92% +1,965.96 1 Comment
coolyo514 82.77 12/17/2009 Outperform 5Y $2.94 +2,105.51% +152.70% +1,952.81 0 Comment
DUTCHMAN67 64.50 12/17/2009 2/16/2012 Outperform 5Y $2.96 +2,089.93% +153.20% +1,936.72 0 Comment
JavaChipFool 70.48 12/22/2009 Outperform 5Y $2.97 +2,081.74% +149.76% +1,931.98 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. pantastic 79.59 12/17/2009 Outperform 5Y $2.98 +2,074.57% +153.04% +1,921.53 0 Comment
NickJ100 76.95 12/17/2009 9/24/2014 Outperform 1Y $3.01 +2,052.82% +152.52% +1,900.31 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. jpmj 67.40 12/18/2009 11/23/2014 Outperform 5Y $3.05 +2,024.59% +154.50% +1,870.09 0 Comment
fiberoptical 48.29 12/18/2009 Outperform 3M $3.06 +2,017.65% +153.43% +1,864.21 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.66 5/3/2017 Outperform 3W $31.31 +107.06% +17.03% +90.03 0 Comment
trackcraighallum 66.58 6/16/2016 Outperform NS $9.92 +553.53% +35.00% +518.53 0 Comment
TrackJimCramer 85.66 7/22/2015 Underperform 3W $25.29 +23.80% +12.87% -10.94 5/3/2017 @ $31.31 0 Comment
TrackGoldmanSach 78.41 6/4/2014 Outperform NS $14.20 +356.34% +45.11% +311.23 0 Comment
TrackRothCapital 76.85 12/20/2012 Outperform NS $10.43 +521.28% +93.44% +427.85 0 Comment
TrackUltraLong < 20 2/6/2012 Underperform NS $9.57 +577.12% +107.88% -469.23 1 Comment
TrackCanaccord 70.47 1/6/2012 Outperform NS $8.41 +670.51% +117.85% +552.66 0 Comment
TrackJMP 85.20 1/5/2012 Outperform NS $8.12 +698.03% +120.36% +577.67 0 Comment
TrackRodmanRen < 20 8/15/2011 Outperform NS $6.74 +861.42% +134.32% +727.11 0 Comment
TrackWedbush 87.62 6/28/2011 Outperform NS $8.03 +706.97% +117.43% +589.55 0 Comment
TrackTheBenchmar 84.12 4/28/2011 Outperform NS $7.45 +769.80% +106.22% +663.58 0 Comment
TrackAurigaUSA 64.47 3/1/2011 Outperform NS $5.65 +1,046.90% +109.09% +937.81 0 Comment
TrackWMBlair 78.94 12/14/2010 Outperform NS $5.72 +1,032.87% +123.39% +909.47 0 Comment
TrackJimCramer 85.66 10/13/2010 Outperform 3W $8.39 +201.43% +79.18% +122.25 7/22/2015 @ $25.29 0 Comment
TrackJefferies 81.09 9/9/2010 Outperform NS $5.17 +1,153.38% +150.14% +1,003.24 0 Comment
TrackRWBaird 88.92 3/4/2010 Outperform NS $4.25 +1,424.71% +148.36% +1,276.34 0 Comment
TrackRodmanRen < 20 2/2/2010 Outperform NS $4.25 +80.24% +14.87% +65.37 8/3/2011 @ $7.66 0 Comment

Featured Broker Partners


Advertisement